PharmaVOICE - 
January 2021
Purchase Issue
In Every Issue
Letter from the Editor
Lighting the way… As we say good riddance to 2020, [...]
By

Taren Grom, Editor

Upfront
DTRA Launches to Democratize and Accelerate Clinical Trials A new [...]
By

PharmaVOICE Staff

Trend Tracking
The industry is moving fast, and our community of experts [...]
By

PharmaVOICE Staff

Artificial Intelligence
AdventHealth, Berg tap AI to Reduce Mortality in COVID-19 Patients [...]
By

PharmaVOICE Staff

On The Cover

Innovator’s Journey
Every entrepreneur’s path is unique, yet they share some core characteristics. They are willing to take calculated risks, they are visionary, they are fearless, and they are always thinking about the next big thing. The statistics are somewhat sobering: 20% of new companies fail in their first year, and only 50% survive through their fifth [...]
By

Kim Ribbink and Taren Grom, Editor

Features

SHOWCASE: Virtual Health: A Virtual Awakening: COVID-19 Brings Healthcare Revolution
Healthcare delivery has undergone a dramatic shift in the wake of the COVID-19 pandemic. Virtual health has been around for more than a decade, but adoption has been slow. However, thanks to advances in technology and the global pandemic that have impacted all areas of health, healthcare is being brought into patients’ homes via technology-enabled [...]
By

PharmaVOICE Staff

How to Enhance Provider and Patient Engagement in Tech-Savvy Healthcare
Pharmaceutical representatives have always been a welcomed resource and consistent office visitor for healthcare providers (HCPs). Today, in a world operating largely virtually, pharma reps are re-strategizing HCP engagement in the same way providers are rethinking patient outreach. For physicians, telehealth has intercepted in-person appointments, and contact tracing has become a priority, limiting office visits. [...]
By

Peter Marchesini, President, Field Solutions, EVERSANA

The Explosion of Virtual Health in the Field of Mental Health
This year has been an incredibly difficult and stressful one due to the COVID-19 pandemic, and for those of us in the United States, the pressures have only been exacerbated by ongoing incidents of racial injustice and political turmoil. These circumstances have all placed an enormous amount of pressure on those who already deal with [...]
By

Kate Cronin, Global CEO, Ogilvy Health

Combating Telehealth Distractions With Innovation
It’s unsurprising that 2020 has spurred rapid growth for digital health. COVID-19 forced patients and healthcare professionals alike to rethink healthcare access, delivery, and management, with technology central to this reimagination. There was no brighter star in this new world than telemedicine. eMarketer reports that in 2020, 41.7 million adults in the United States have [...]
By

Chris Jankoski, Digital Strategist, Ogilvy Health

SHOWCASE: High-Science Brands: Laying the Groundwork for High-Science Brands
Cell and gene therapies, immunotherapies, RNA interference (RNAi) – innovative scientific breakthroughs have the potential to change the course of treatment for severe diseases such as cancer and devastating rare diseases. The gene therapy market is predicted to rise to .67 billion by 2027 from .61 billion in 2019 thanks to technological advances aimed at [...]
By

PharmaVOICE Staff

High-Efficiency Commercialization for High-Science Brands
In the expanding arena of high-science brands, or high-stake, complex therapies, time is not a luxury that patients, providers or pharma manufacturers have on their side. Patients with rare and complex diseases, cancer patients in particular, need access to life-saving therapies without delay. Providers with cancer patients must understand how to navigate the system and [...]
By

Suzanne Greenwood, RN, BSN, Senior VP, Strategic Solutions, EVERSANA and Chien Sun, Ph.D., Senior Principal, EVERSANA MANAGEMENT CONSULTING

Print Is Alive and Well
The pandemic has increased the use of digital solutions, but print still brings plenty of value to pharma marketing. For the past three holiday shopping seasons, Amazon, the second-most valuable company in the United States, valued at .7 trillion, has issued printed toy catalogs. Why would such a successful e-commerce company based on a digital [...]
By

Robin Robinson

Digital Influencers
Influencers have the power to positively change the status quo because of their authority, knowledge, position, or relationship with their audience. The global digital health market is expected to generate revenue of 4.1 billion, progressing at a 21.8% CAGR during the forecast period (2020-2030), according to one market analyst. The market is growing due to [...]
By

PharmaVOICE Staff

Brigham Hyde, Ph.D. — Data Is Transforming The Landscape
From the rise of personalized medicine and value-based healthcare to evolving commercial strategies, the effective utilization of data is critical to solving for better patient outcomes. Brigham Hyde, Ph.D., a highly regarded speaker and thought leader on the value of data and analytics across the life sciences, believes it’s more critical than to reimagine traditional [...]
By

Brigham Hyde, Ph.D., President, Data & Analytics, EVERSANA

Dan Wilmer — Putting Brands At The Center Of A Patient’s World
To connect with consumers, you need to fit into their lives on their terms and empower them with information. As a digital strategist and innovator with a history of building large-scale consumer health businesses, Dan Wilmer recognizes the importance of creating strategies, products, and tools that can result in a meaningful and measurable experience for [...]
By

Dan Wilmer, Executive VP and Chief Product Officer, InStep Health

Breaking New Ground: The Prix Galien Awards 2020
At the end of October, 2020, The Galien Foundation presented its 2020 Prix Galien Awards to six products in four categories: Best Pharmaceutical Agent; Best Biotechnology Product; Best Medical Technology; and Best Digital Health Product, a new category for 2020. Created in 1970, the Prix Galien is an international award recognizing innovating therapies that represent [...]
By

Carolyn Gretton

The Health Tech Industry: Thriving at Last
2020 was a tough year all around, but the health tech industry emerges as a winner during the pandemic. PharmaVOICE started tracking innovation in health technology a couple of years ago. As part of this reporting, we have covered some interesting solutions. In 2020 alone, there was a great deal of activity, much of which [...]
By

Robin Robinson

Commanders & Chiefs: Biopharma Chief Executive Officers
CEOs of biopharma organizations face unprecedented challenges as they lead their companies amid a global pandemic, shoring up their organizations during turmoil, and learning valuable lessons along the way. David Lucchino Maintaining an Entrepreneurial Edge Over the past year, we have put significant focus on maintaining and fostering our culture at a time when the [...]
By

PharmaVOICE Staff

Executive Perspective: The Right Man for the Job A Conversation with Andy Plump, M.D., Ph.D.
Timing in life is everything, and for Andy Plump, M.D., Ph.D., taking on the role as president of R&D at Takeda in 2015 has proven to be advantageous not only for the 239-year-old company at a time when it needed a fresh approach, but also for patients around the globe. Back in 2014, Andy was [...]
By

Dr. Andy Plump, President, R&D, Takeda

FEEDBACK